Innoviva (INVA) Competitor Comparison
We are evaluating the key criteria listed to compare Innoviva (INVA) against its competitors in the Biotechnology industry.
Market Capitalization
129 / 368Gross Profits
24 / 278Total Revenue
41 / 300EBITDA
13 / 337Free Cashflow
15 / 352Quick Ratio
136 / 357Earnings per Share
24 / 359Dividend yield
0 / 6Total Cash
169 / 358Performance 3 years
88 / 368Performance 5 years
90 / 368Performance 10 years
83 / 368Linearity 3 years
24 / 368Linearity 5 years
156 / 368Linearity 10 years
78 / 368Total Rank
159 / 368Dividend Rank
39 / 368Valuation Rank
131 / 368Piotroski Rank
185 / 368Muliplier Rank
367 / 368Free Cashflow - INVA ranking 15 / 352
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.